BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Noor MT, Manoria P. Immune Dysfunction in Cirrhosis. J Clin Transl Hepatol. 2017;5:50-58. [PMID: 28507927 DOI: 10.14218/jcth.2016.00056] [Cited by in Crossref: 20] [Cited by in F6Publishing: 43] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Ali FE, Abd El-Aziz MK, Sharab EI, Bakr AG. Therapeutic interventions of acute and chronic liver disorders: A comprehensive review. World J Hepatol 2023;15:19-40. [PMID: 36744165 DOI: 10.4254/wjh.v15.i1.19] [Reference Citation Analysis]
2 Liptak P, Nosakova L, Rosolanka R, Skladany L, Banovcin P. Acute-on-chronic liver failure in patients with severe acute respiratory syndrome coronavirus 2 infection. World J Hepatol 2023;15:41-51. [PMID: 36744167 DOI: 10.4254/wjh.v15.i1.41] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Al-Rawi TSS, Al-Ani RM. Liver dysfunction-related COVID-19: A narrative review. World J Meta-Anal 2023; 11(1): 5-17 [DOI: 10.13105/wjma.v11.i1.5] [Reference Citation Analysis]
4 Beran A, Mhanna A, Mhanna M, Hassouneh R, Abuhelwa Z, Mohamed MFH, Sayeh W, Musallam R, Assaly R, Abdeljawad K. Real-world effectiveness of COVID-19 vaccination in liver cirrhosis: a systematic review with meta-analysis of 51,834 patients. Proc (Bayl Univ Med Cent) 2023;36:151-6. [PMID: 36876272 DOI: 10.1080/08998280.2023.2165344] [Reference Citation Analysis]
5 He T, Ling N, Zhang G, Xiang D, Hu P, Peng M, Cai D, Zhang D, Chen M, Ren H. Decreased antibody response to influenza vaccine with an enhanced antibody response to subsequent SARS-CoV-2 vaccination in patients with chronic hepatitis B virus infection. Immun Inflamm Dis 2023;11:e759. [PMID: 36705404 DOI: 10.1002/iid3.759] [Reference Citation Analysis]
6 Mark JD, Park T, Velez Quinones V, Isaac S. Rare extension of pancreatic pseudocyst with Mycobacterium abscessus into the iliopsoas muscle. BMJ Case Rep 2022;15:e252777. [PMID: 36319038 DOI: 10.1136/bcr-2022-252777] [Reference Citation Analysis]
7 Drácz B, Czompa D, Müllner K, Hagymási K, Miheller P, Székely H, Papp V, Horváth M, Hritz I, Szijártó A, Werling K. The Elevated De Ritis Ratio on Admission Is Independently Associated with Mortality in COVID-19 Patients. Viruses 2022;14. [PMID: 36366457 DOI: 10.3390/v14112360] [Reference Citation Analysis]
8 Yoshida Y, Chu S, Fox S, Zu Y, Lovre D, Denson JL, Miele L, Mauvais-Jarvis F. Sex differences in determinants of COVID-19 severe outcomes - findings from the National COVID Cohort Collaborative (N3C). BMC Infect Dis 2022;22:784. [PMID: 36224551 DOI: 10.1186/s12879-022-07776-7] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 da Costa VD, Wiggers WJ, Ivantes CAP, da Fonseca RJM, Dávila AMR, Moreira OC, Ferreira BIDS, de Paula VS, da Silva LL, Santos AC, Villar LM. Characteristics of COVID-19 Infection in a Hospitalized Autoimmune Hepatitis Patient. Pathogens 2022;11:1054. [DOI: 10.3390/pathogens11091054] [Reference Citation Analysis]
10 Aquino-matus J, Uribe M, Chavez-tapia N. COVID-19: Current Status in Gastrointestinal, Hepatic, and Pancreatic Diseases—A Concise Review. TropicalMed 2022;7:187. [DOI: 10.3390/tropicalmed7080187] [Reference Citation Analysis]
11 Kim JA, Park SJ, Choi S, Chang J, Jeong S, C Ahn J, Lee G, Son JS, Park SM. Association of the presence of allergic disease with subsequent risk of liver cancer in a nationwide retrospective cohort among Koreans. Sci Rep 2022;12:9856. [PMID: 35701586 DOI: 10.1038/s41598-022-14147-4] [Reference Citation Analysis]
12 Nguyen DT, Kha NH, Thai NTH, Kha TD, Bo PK, Dang KTD, Tran HY, Nguyen T. Correlation between the Lymphocyte-To-Monocyte Ratio (LMR) and Child–Pugh and MELD/MELDNa Scores in Vietnamese Patients with Liver Cirrhosis. Gastroenterology Insights 2022;13:182-91. [DOI: 10.3390/gastroent13020019] [Reference Citation Analysis]
13 Elnaggar M, Abomhya A, Elkhattib I, Dawoud N, Doshi R. COVID-19 and liver diseases, what we know so far. World J Clin Cases 2022; 10(13): 3969-3980 [DOI: 10.12998/wjcc.v10.i13.3969] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
14 de Jesus RP, de Carvalho JF, de Oliveira LPM, Cunha CM, Alves TCHS, Vieira STB, Figueiredo VM, Bueno AA. Metabolic and nutritional triggers associated with increased risk of liver complications in SARS-CoV-2. World J Hepatol 2022;14:80-97. [PMID: 35126841 DOI: 10.4254/wjh.v14.i1.80] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Khalaf SA, Patel P, Caruso CR, Parrett T, Bran A. CNS Histoplasmosis as a Gliosarcoma mimicker: The diagnostic dilemma of solitary brain lesions. IDCases 2022;27:e01364. [PMID: 35024338 DOI: 10.1016/j.idcr.2021.e01364] [Reference Citation Analysis]
16 Mallik M, Singhai A, Khadanga S, Ingle V. The Significant Morbidity and Mortality Indicators in Patients of Cirrhosis. Cureus 2022. [DOI: 10.7759/cureus.21226] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Philips CA, Rela M, Soin AS, Gupta S, Surendran S, Augustine P. Critical Update on the Diagnosis and Management of COVID-19 in Advanced Cirrhosis and Liver Transplant Recipients. J Clin Transl Hepatol 2021;9:947-59. [PMID: 34966658 DOI: 10.14218/JCTH.2021.00228] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
18 Tarik Aslan A, Yasemin Balaban H. An overview of SARS-COV-2-related hepatic injury. Hepatol Forum 2021;2:122-7. [PMID: 35784909 DOI: 10.14744/hf.2021.2021.0020] [Reference Citation Analysis]
19 Saviano A, Wrensch F, Ghany MG, Baumert TF. Liver Disease and Coronavirus Disease 2019: From Pathogenesis to Clinical Care. Hepatology 2021;74:1088-100. [PMID: 33332624 DOI: 10.1002/hep.31684] [Cited by in Crossref: 40] [Cited by in F6Publishing: 44] [Article Influence: 20.0] [Reference Citation Analysis]
20 Simons-Linares CR, Abushamma S, Romero-Marrero C, Bhatt A, Lopez R, Jang S, Vargo J, Stevens T, O'Shea R, Carey W, Chahal P. Clinical Outcomes of Acute Pancreatitis in Patients with Cirrhosis According to Liver Disease Severity Scores. Dig Dis Sci 2021;66:2795-804. [PMID: 32892261 DOI: 10.1007/s10620-020-06575-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
21 Neshat SY, Quiroz VM, Wang Y, Tamayo S, Doloff JC. Liver Disease: Induction, Progression, Immunological Mechanisms, and Therapeutic Interventions. Int J Mol Sci 2021;22:6777. [PMID: 34202537 DOI: 10.3390/ijms22136777] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
22 Lin J, Bao B, Khurram NA, Halsey K, Choi JW, Wang L, Tran TML, Liao WH, Feldman MD, Zhang PJ, Wu J, Bai HX. Chronic liver disease not a significant comorbid condition for COVID-19. Sci Rep 2021;11:11734. [PMID: 34083670 DOI: 10.1038/s41598-021-91238-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
23 Li TH, Liu CW, Huang CC, Tsai YL, Huang SF, Yang YY, Tsai CY, Hou MC, Lin HC. Non-Selective Beta-Blockers Decrease Infection, Acute Kidney Injury Episodes, and Ameliorate Sarcopenic Changes in Patients with Cirrhosis: A Propensity-Score Matching Tertiary-Center Cohort Study. J Clin Med 2021;10:2244. [PMID: 34064207 DOI: 10.3390/jcm10112244] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
24 Calapod OP, Marin AM, Onisai M, Tribus LC, Pop CS, Fierbinteanu-Braticevici C. The Impact of Increased Fib-4 Score in Patients with Type II Diabetes Mellitus on Covid-19 Disease Prognosis. Medicina (Kaunas) 2021;57:434. [PMID: 33946377 DOI: 10.3390/medicina57050434] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
25 Cardoso CC, Matiollo C, Pereira CHJ, Fonseca JS, Alves HEL, da Silva OM, de Souza Menegassi V, Dos Santos CR, de Moraes ACR, de Lucca Schiavon L, Santos-Silva MC. Patterns of dendritic cell and monocyte subsets are associated with disease severity and mortality in liver cirrhosis patients. Sci Rep 2021;11:5923. [PMID: 33723292 DOI: 10.1038/s41598-021-85148-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
26 Uppuluri A, Zarbin MA, Bhagat N. Endogenous endophthalmitis in patients with intravenous opioid use: demographics and associated comorbidities. Int Ophthalmol 2021;41:1513-20. [PMID: 33506370 DOI: 10.1007/s10792-021-01709-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
27 Pampalone M, Corrao S, Amico G, Vitale G, Alduino R, Conaldi PG, Pietrosi G. Human Amnion-Derived Mesenchymal Stromal Cells in Cirrhotic Patients with Refractory Ascites: A Possible Anti-Inflammatory Therapy for Preventing Spontaneous Bacterial Peritonitis. Stem Cell Rev Rep 2021;17:981-98. [PMID: 33389680 DOI: 10.1007/s12015-020-10104-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
28 Marjot T, Webb GJ, Barritt AS 4th, Moon AM, Stamataki Z, Wong VW, Barnes E. COVID-19 and liver disease: mechanistic and clinical perspectives. Nat Rev Gastroenterol Hepatol 2021;18:348-64. [PMID: 33692570 DOI: 10.1038/s41575-021-00426-4] [Cited by in Crossref: 175] [Cited by in F6Publishing: 178] [Article Influence: 87.5] [Reference Citation Analysis]
29 Lingiah VA, Pyrsopoulos NT. Bacterial Infections in Cirrhotic Patients in a Tertiary Care Hospital. J Clin Transl Hepatol 2021;9:32-9. [PMID: 33604253 DOI: 10.14218/JCTH.2020.00076] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
30 Jamil M, Kichloo A, Soni RG, Jamal S, Khan MZ, Patel M, Albosta MS, Aljadah M, Bailey B, Singh J, Kanjwal K. Coexisting Cirrhosis Worsens Inpatient Outcomes in Patients With Infective Endocarditis: A Cross-Sectional Analysis of the National Inpatient Sample 2013-2014. Cureus 2020;12:e11826. [PMID: 33409068 DOI: 10.7759/cureus.11826] [Reference Citation Analysis]
31 Chiriac S, Stanciu C, Singeap AM, Sfarti CV, Cuciureanu T, Trifan A. Prognostic value of neutrophil-to-lymphocyte ratio in cirrhotic patients with acute-on-chronic liver failure. Turk J Gastroenterol 2020;31:868-76. [PMID: 33625999 DOI: 10.5152/tjg.2020.19838] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
32 Tischfield D, Gurevich A, Johnson O, Gayatman I, Nadolski GJ, Kaplan DE, Furth E, Hunt SJ, Gade TPF. Transarterial embolization modulates the immune response within target and non-target hepatocellular carcinomas.. [DOI: 10.1101/2020.11.07.372896] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
33 Hartnell F, Esposito I, Swadling L, Brown A, Phetsouphanh C, de Lara C, Gentile C, Turner B, Dorrell L, Capone S, Folgori A, Barnes E, Klenerman P. Characterizing Hepatitis C Virus-Specific CD4(+) T Cells Following Viral-Vectored Vaccination, Directly Acting Antivirals, and Spontaneous Viral Cure. Hepatology 2020;72:1541-55. [PMID: 32012325 DOI: 10.1002/hep.31160] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
34 Mizusawa M, Vindenes T, Buckley S, Armstrong C. A case series of rapidly growing mycobacterial catheter-related bloodstream infections among immunocompetent patients. J Clin Tuberc Other Mycobact Dis 2020;21:100196. [PMID: 33195824 DOI: 10.1016/j.jctube.2020.100196] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
35 Huang RJ, Banerjee S, Friedland S, Ladabaum U. Risk of ambulatory colonoscopy in patients with cirrhosis: a propensity-score matched cohort study. Endosc Int Open 2020;8:E1495-501. [PMID: 33043119 DOI: 10.1055/a-1242-9958] [Reference Citation Analysis]
36 Sawalha K, Kadado AJ, Gupta K, Al-Akchar M, Battisha A, Abozenah M, Salerno C, Gupta M, Khan A, Islam AM. Outcomes of MitraClip Placement in Patients With Liver Cirrhosis. Cardiovasc Revasc Med 2021;29:50-3. [PMID: 32839129 DOI: 10.1016/j.carrev.2020.08.014] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
37 Hametner-schreil S. Immunotherapy in hepatocellular carcinoma. memo 2020;13:218-222. [DOI: 10.1007/s12254-020-00592-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
38 Huston JH, Hemnes AR. Parenteral Prostacyclin Use in Pulmonary Arterial Hypertension. Pulmonary Hypertension 2020. [DOI: 10.1007/978-3-030-52787-7_10] [Reference Citation Analysis]
39 Queck A, Thomas D, Jansen C, Schreiber Y, Rüschenbaum S, Praktiknjo M, Schwarzkopf KM, Mücke MM, Schierwagen R, Uschner FE, Meyer C, Clària J, Zeuzem S, Geisslinger G, Trebicka J, Lange CM. Pathophysiological role of prostanoids in coagulation of the portal venous system in liver cirrhosis. PLoS One 2019;14:e0222840. [PMID: 31644538 DOI: 10.1371/journal.pone.0222840] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
40 Keenan BP, Fong L, Kelley RK. Immunotherapy in hepatocellular carcinoma: the complex interface between inflammation, fibrosis, and the immune response. J Immunother Cancer. 2019;7:267. [PMID: 31627733 DOI: 10.1186/s40425-019-0749-z] [Cited by in Crossref: 74] [Cited by in F6Publishing: 76] [Article Influence: 18.5] [Reference Citation Analysis]
41 Molokwu O, Young BM, Singh M, Menezes K, Mian R. Reactivation of Chronic Hepatitis C as a Potential Trigger for Guillain-Barré Syndrome. Cureus 2019;11:e5244. [PMID: 31565642 DOI: 10.7759/cureus.5244] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
42 Peng JL, Techasatian W, Hato T, Liangpunsakul S. Role of endotoxemia in causing renal dysfunction in cirrhosis. J Investig Med 2020;68:26-9. [PMID: 31324695 DOI: 10.1136/jim-2019-001056] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
43 Wang X, Wu B. Critical issues in the diagnosis and treatment of liver cirrhosis. Gastroenterol Rep (Oxf) 2019;7:227-30. [PMID: 31413829 DOI: 10.1093/gastro/goz024] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
44 Jamil Z, Durrani AA. Assessing the outcome of patients with liver cirrhosis during hospital stay: A comparison of lymphocyte/monocyte ratio with MELD and Child-Pugh scores. Turk J Gastroenterol 2018;29:308-15. [PMID: 29755015 DOI: 10.5152/tjg.2018.17631] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
45 Kaliannan K. Compromise of α-Defensin Function in Liver Cirrhosis Facilitates the Toxic Relationship Between Gut Permeability and Endotoxemia. Dig Dis Sci 2018;63:2492-4. [PMID: 30008088 DOI: 10.1007/s10620-018-5197-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
46 Peleg N, Sneh Arbib O, Issachar A, Cohen-Naftaly M, Braun M, Shlomai A. Noninvasive scoring systems predict hepatic and extra-hepatic cancers in patients with nonalcoholic fatty liver disease. PLoS One. 2018;13:e0202393. [PMID: 30106985 DOI: 10.1371/journal.pone.0202393] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 3.4] [Reference Citation Analysis]
47 Lan P, Wang SJ, Shi QC, Fu Y, Xu QY, Chen T, Yu YX, Pan KH, Lin L, Zhou JC, Yu YS. Comparison of the predictive value of scoring systems on the prognosis of cirrhotic patients with suspected infection. Medicine (Baltimore) 2018;97:e11421. [PMID: 29995791 DOI: 10.1097/MD.0000000000011421] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
48 Mukaida N, Nakamoto Y. Emergence of immunotherapy as a novel way to treat hepatocellular carcinoma. World J Gastroenterol 2018; 24(17): 1839-1858 [PMID: 29740200 DOI: 10.3748/wjg.v24.i17.1839] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 23] [Article Influence: 3.8] [Reference Citation Analysis]
49 Vega-Magaña N, Galiana A, Jave-Suárez LF, Garcia-Benavides L, Del Toro-Arreola S, Andrade-Villanueva JF, González-Hernández LA, Cremades R, Aguilar-Lemarroy A, Flores-Miramontes MG, Haramati J, Meza-Arroyo J, Bueno-Topete MR. Microbiome alterations are related to an imbalance of immune response and bacterial translocation in BDL-rats. Iran J Basic Med Sci 2020;23:178-85. [PMID: 32405360 DOI: 10.22038/IJBMS.2019.36487.8753] [Cited by in F6Publishing: 1] [Reference Citation Analysis]